Document is current
Any future updates will be listed below
-
Authors
Fang, Chih-Hao
Cheng, Ya Fang
Lin, Shian-Ren
Lai, Wan-Yu
Liao, Li-Ren
Chiu, Yen-Ling
Lee, Jan-Mou
-
Funding
Funding for this research was provided by:
FullHope Biomedical Co., Ltd.
- License Information
-
More Information
Article History
Received: 15 April 2024
Accepted: 26 July 2024
First Online: 8 August 2024
Declarations
:
: The designation of this study complied with the Declaration of Helsinki. The study protocol was reviewed and approved by the Institutional Review Board of Far Eastern Memorial Hospital (approval code: 109007-F). All participants signed the informed consent form before blood collection.
: Not applicable.
: EBaT8 is patent filed by FullHope Biomedical Co., Ltd. in Taiwan (patent no I840994). Chih-Hao Fang, Ya Fang Cheng, Shian-Ren Lin, and Wan-Yu Lai are employees of FullHope Biomedical Co., Ltd. Jan-Mou Lee is the CEO of FullHope Biomedical. Co., Ltd. In addition to the above, the authors declare no other conflict of interest to this study.
